Books by Subject

Research

  • 2006 Springer
    edited by Zili Sloboda and William J. Bukoski.
    I: HISTORICAL OVERVIEW: The emerging science of drug abuse prevention / William J. Bukoski -- II: SOCIAL CONTEXTS OF PREVENTION: Effective mass media strategies for drug abuse prevention campaigns / Philip Palmgreen and Lewis Donohew -- Drug abuse prevention curricula in schools / Gilbert J. Botvin and Kenneth W. Griffin -- Dissemination of research-based family intervention for the prevention of substance abuse / Karol L. Kumpfer and Steve Adler -- Peers and the prevention of adolescent drug use -- / E. R. Oetting and R. S. Lynch -- Mobilizing communities to reduce risk for drug abuse: a comparison of two strategies / Michael W. Arthur, Charles D. Ayers, Kelly A. Graham, and J. David Hawkins -- Community-focused drug abuse prevention / Barry M. Kibel and Harold D.Holder -- Drug abuse prevention in the workplace / Royer F. Cook -- Prevention approaches to methadone treatment settings: children of drug abuse treatment clients / Richard F. Catalano, Kevin P. Haggerty, and Randy R. Gainey -- III: PREVENTION AS SOCIAL CONTROL: Drug tests in prevention research / Robert L. DuPont and Keith E. Saylor -- Anti-drug-abuse policies on prevention strategies / Mary Ann Pentz -- IV: THEORETICAL AND EMPIRICAL FOUNDATIONS OF PREVENTION: Forging a relationship between drug abuse epidemiology and drug abuse prevention / Zili Sloboda -- Risk and protective factors of adolescent drug use: implications for prevention programs / Judith S. Brook. David W. Brook, Linda Richter, and Martin Whiteman -- Bridging the gap between substance use prevention theory and practice / Brian R. Flay and John Petraitis -- Preventive intervention targeting precursors / John E. Lochman -- Designing prevention programs: the developmental perspective / Marvin W. Berkowitz and Audrey L. Begun -- V: SPECIAL POPULATIONS: Gender issues in substance abuse prevention / Louise Ann Rohrbach and Joel Milam -- Preventing substance use among Latino youth / Charles R. Martinez, Jr., J. Mark Eddy, and David S. DeGarmo -- African-American substance use epidemiology and prevention issues / William L. Turner and Michael J. Hench -- The effectiveness of alcohol and drug abuse prevention among American-Indian youth / Fred Beauvais and Joseph E. Trimble -- Drug abuse prevention research for Asian and Pacific Islander Americans / W. William Chen -- VI: INTERACTIONS BETWEEN BIOLOGY AND SOCIAL CONTEXT: RISKS FOR MULTIPLE BEHAVIORAL AND MENTAL DISORDERS: Basic science and drug abuse prevention: neuroscience, learning, and personality perspectives / Michael T. Bardo, Thomas Kelly, Donald R. Lynam, and Richard Milich -- Cross-national comparisons of co-morbidities between substance use disorders and mental disorders / Ronald C. Kessler, Sergio Aguilar-Gaxiola, Laura Andrade, Rob Bijl ... [et al.] -- Drug abuse research for high-risk youth / Leona L. Eggert and Brooke P. Randell -- Research designs for family studies / Michael Vanyukov, Howard Moss, and Ralph E. Tarter -- VII: RESEARCH DESIGN, MEASUREMENT, AND DATA ANALYTIC ISSUES: Design principles and their application in preventive field trials / C. Hendricks Brown -- Major data analysis issues in drug abuse prevention research / David P. MacKinnon and James H. Dwyer -- Metholological considerations to prevention research / Linda M. Collins and Brian P. Flaherty -- Prevention program implementation / Steven Schinke and Kristin Cole -- Family management practices: research design and measurement issues / Thomas J. Dishion, Bert Burraston, and Fuzhong Li -- Power analysis models and methods: a latent variable framework for power estimation and analysis / Terry E. Duncan, Susan C. Duncan, and Puzhong Li -- VIII: DRUG ABUSE PREVENTION: A LOOK TO THE FUTURE: Application of computer technology to drug abuse prevention / Kris Bosworth -- Putting science into practice / Gale Held.
  • 2014 CRCnetBASE
    edited by Carolyn D. Berdanier, Johanna T. Dwyer, David Heber.
    "Beginning with an overview of food and food constituents, the book outlines current nutrient analysis systems, techniques for data analysis, and food labeling. The book reviews nutrition science including terminology, biochemistry, nutrient-nutrient interactions, and comparative nutrition. There is a detailed assessment in section three on nutritional needs throughout the lifecycle. It highlights exercise and the value of vegetarian diets in health promotion and disease prevention. Section four considers issues surrounding nutritional assessment, screening, and monitoring tools including questionnaires, and anthropometric-, psychological-, and energy-assessments--Provided by publisher.
  • 2012 Springer
    Sandra L. Christenson, Amy L. Reschly, Cathy Wylie, editors.
    pt. 1. What is student engagement? -- pt. 2. Engagement as linked to motivational variables -- pt. 3. Engagement and contextual influences -- pt. 4. Student engagement : determinants and student outcomes -- pt. 5. Measurement issues, instruments, and approaches.
  • 2008 Springer
    edited by Gertrude Hirsch Hadorn ... [et al.].
  • 2006
    Trisha Greenhalgh.
    Status: Not Checked OutLane Catalog Record
    Why read papers at all? -- Searching the literature -- Getting your bearings: what is this paper about? -- Assessing methodological quality -- Statistics for the non-statistician -- Papers that report drug trials -- Papers that report diagnostic or screening tests -- Papers that summarise other papers (systematic reviews and meta-analyses) -- Papers that tell you what to do (guidelines) -- Papers that tell you what things cost (economic analyses) -- Papers that go beyond numbers (qualitative research) -- Papers that report questionnaire research (surveys) -- Getting evidence into practic.
  • 2010
    Trisha Greenhalgh.
    Status: Not Checked OutLane Catalog Record
    Why read papers at all? -- Searching the literature -- Getting your bearings : what is this paper about? -- Assessing methodological quality -- Statistics for the non-statistician -- Papers that report trials of drug treatments and other simple interventions -- Papers that report trials of complex interventions -- Papers that report diagnostic or screening tests -- Papers that summarise other papers (systematic reviews and meta-analyses) -- Papers that tell you what to do (guidelines) -- Papers that tell you what things cost (economic analyses) -- Papers that go beyond numbers (qualitative research) -- Papers that report questionnaire research -- Papers that report quality improvement case studies -- Getting evidence into practice.
  • 2011 Springer
    Willo Pequegnat, Ellen Stover, Cheryl Anne Boyce, editors.
    Grantsmanship : necessary but not sufficient strategies for success / Willo Pequegnat -- Community-based collaborations : designing, conducting and sustaining prevention programs / Mary M. McKay, Carl C. Bell, and Clair A. Blake -- Funding opportunity announcements / Jean Noronha -- Selecting the appropriate research mechanism : finding the right match / Cheryl Anne Boyce and Courtney Ferrell Aklin -- Selecting issues and hypotheses for a research proposal / Spero M. Manson -- Electronic submission process / Jean Noronha -- The review process / Anita Miller Sostek -- Common mistakes in proposal writing and how to avoid them / Susan Folkman and Willo Pequegnat -- Reading between the lines of your summary statement / William Lyman, Bonita Stanton, and Willo Pequegnat -- The award process / Ellen Stover -- So you were awarded your grant, now what? / Seth C. Kalichman -- Developing a theoretical framework and rationale for a research proposal / Gregory M. Herek -- How do you formulate a testable exciting hypothesis? / Robyn Dawes -- Qualitative inquiry : an end not just a means / Margaret E. Bentley, Elizabeth E. Tolley, and Willo Pequegnat -- Issues in assessment in research proposals / Helena Chmura Kraemer -- Using technology and the Internet in research / Joseph A. Konstan and William West -- Designing an intervention / Jose Szapocznik, Willo Pequegnat, and Guillermo Prado -- Designing an adequate control group / Thomas J. Coates -- Human subject protection and special population issues / Christine Moretto Wishnoff ... [et al.] -- Animal welfare and behavior / Kevin Quinn and Richard Nakamura -- Developing a resume and presenting your research team / Rayford Kytle and Cheryl Anne Boyce -- Writing the data analysis plan / A.T. Panter -- Developing a budget and financial justification / Masud Rahman -- Developing a quality control/quality assurance program / Lisa C. Strader and Willo Pequegnat -- Applying for training, career development, and early-stage research grants / Donna Mayo -- Cost-effectiveness : a key step in technology transfer / Steven D. Pinkerton and David R. Holtgrave -- Disseminating research findings to service providers and communities / Jeffrey A. Kelly -- Developing a plan for data sharing / Christine Bachrach and Michael Spittel.
  • 2011
    Robert A. Day and Barbara Gastel.
    Status: Not Checked OutLane Catalog Record
    What is scientific writing? -- Historical perspectives -- Approaching a writing project -- What is a scientific paper? -- Ethics in scientific publishing -- Where to submit your manuscript -- How to prepare the title -- How to list the authors and addresses -- How to prepare the abstract -- How to write the introduction -- How to write the materials and methods section -- How to write the results -- How to write the discussion -- How to state the acknowledgments -- How to cite the references -- How to design effective tables -- How to prepare effective graphs -- How to prepare effective photographs -- Rights and permissions -- How to submit the manuscript -- The review process (how to deal with editors) -- The publishing process (how to deal with proofs) -- How to write a review paper -- How to write opinion (book reviews, editorials, and letters to the editor) -- How to write a book chapter or a book -- How to write for the public -- How to present a paper orally -- How to prepare a poster -- How to write a conference report -- Use and misuse of English -- Avoiding jargon -- How and when to use abbreviations -- Writing clearly across cultures and media -- How to write science in English as a foreign language -- How to write a thesis -- How to prepare a curriculum vitae -- How to prepare grant proposals and progress reports -- How to write a recommendation letter- and how to ask for one -- How to work with the media -- How to provide peer review -- How to seek a scientific-communication career -- Appendix 1. Selected journal title word abbreviations -- Appendix 2. Words and expressions to avoid -- Appendix 3. Prefixes and abbreviations for SI (système international) units -- Appendix 4. Some helpful websites -- Glossary of technical terms.
  • 2010 ProQuest Safari
    Natalie Canavor and Claire Meirowitz.
    "This Element is an excerpt from 'The truth about the new rules of business writing' by Natalie Canavor and Claire Meirowitz. How to write successful proposals and grant applications"--Resource description page.
  • 2006 CRCnetBASE
    George A. Peters, Barbara J. Peters.
  • 2012 Springer
    Jan Schildmann...[et al.], editors.
    Part 1. Historical and Socio-Cultural Contexts in Medical Research / British Responses to Nazi Medical War Crimes / Fiona McClenaghan -- History and its Relevance in the Development and Teaching of Research Ethics / Rael D. Strous -- Human Embryo Research and Islamic Bioethics: A View from Iran / Mansooreh Saniei -- From Farming to Pharming: Transcending of Bodily Existence as a Question of Medical Ethics in an Intercultural Context / Axel Siegemund -- Introduction / Jan Schildmann, Verena Sandow, Oliver Rauprich and Jochen Vollmann -- Part 2. Considerations on Ethical and Legal Regulations for Medical Research / Rethinking the Therapeutic Obligation in Clinical Research / Nunziata Comoretto -- Biomedical Research in Developing Countries and International Human Rights Law / Ilja R. Pavone -- Research Involving Human Subjects and Human Biological Material from a European Patent Law Perspective. Autonomy, Commodification, Patentability / Tomasz Zimny -- The Development and Validation of a Guide for Peruvian Research Ethics Committees to Assist in the Review of Ethical-Scientific Aspects of Clinical Trials / Susy Olave Quispe, Duilio Fuentes Delgado, Gabriela Minaya Martínez, Rosa Surco Ibarra and Martín Yagui Moscoso, et al. -- Part 3. Conflicts in Medical Research / Conflicts of Interest in Medical Research: What can Ethics Contribute? / Verena Sandow, Jan Schildmann and Jochen Vollmann -- Research Ethics in Genomics Research: Feedback of Individual Genetic Data to Research Participants / Annelien L. Bredenoord and Johannes J. M. van Delden -- Regulating "Higher Risk, No Direct Benefit" Studies with Children: Challenging the US Federal Regulations / Anna E. Westra, Jan M. Wit, Rám N. Sukhai and Inez D. de Beaufort -- Part 4. New Developments in Medical Research and Ethical Implications / A Paradigm Change in Research Ethics / Rieke van der Graaf and Johannes J. M. van Delden -- Translation of Cancer Molecular Biomarkers: Ethical and Epistemological Issues / Flavio D'Abramo and Cecilia Guastadisegni -- Rethinking the Ethics of Human Biomedical Non-Interventional Research / Kristi L{tilde}ouk.
  • 2014 WHO
    Also available: Print – 2014
  • 2014 CRCnetBASE
    edited by Victoria Stodden, Friedrich Leisch, Roger D. Peng.
    Part 1. Tools -- part 2. Practices and guidelines -- part 3. Platforms.
  • v. 1-<5>, 1986-<88>
    editor, Mukta M. Webber ; associate editor, Lea I. Sekely.
    Status: Not Checked OutLane Catalog Record
    v. 1. Carcinomas of the esophagus and colon.--v. 2. Carcinomas of the liver and pancreas.--v. 3. Carcinomas of the mammary gland, uterus, and skin.--v. 4. Carcinomas of the urinary bladder and kidney.--v. 5. Carcinoma of the prostate and testis.
  • 2007 ebrary
    Leon S. Robertson.
    Injury and the role of epidemiology -- Energy characteristics and control strategies -- Research objectives and usable data -- Injury severity -- Injury statistics -- National injury surveillance -- Local injury surveillance -- The use and abuse of causal analysis -- Research designs and data analysis -- Human factors -- Evaluation of programs to change human factors voluntarily -- Evaluation of laws and regulations directed at individual behavior -- Evaluation of agent, vehicle and environmental modifications -- Evaluation of post-injury treatment and rehabilitation -- Injury epidemiology and economics -- Summation of principles.
    Also available: Print – 2007
  • 2000- NCBI Bookshelf
    [Institut National de la Santé et de la Recherche Médicale].
    A collection of syntheses of the international scientific literature and recommendations on public health problems, by Inserm's expert advisory groups.
  • 2005 Springer
    edited by Wolfgang Walz.
  • 2015 ScienceDirect
    Ülo Maiväli, University of Tartu, Institute of Technology.
  • 2006
    Stephen H. Gehlbach.
    Status: Not Checked OutLane Catalog Record
  • 2013 CRCnetBASE
    edited by Ding-Geng Chen, Jianguo Sun, Karl E. Peace.
    "Preface The aim of this book is to present in a single volume an overview and latest developments in time-to-event interval-censored methods along with application of such methods. The book is divided into three parts. Part I provides an introduction and overview of time-to-event methods for interval-censored data. Methodology is presented in Part II. Applications and related software appear in Part III. Part I consists of two chapters. In Chapter 1, Sun and Li present an overview of recent developments, with attention to nonparametric estimation and comparison of survival functions, regression analysis, analysis of multivariate clustered- and analysis of competing risks interval-censored data. In Chapter 2, Yu and Hsu provide a review of models for interval-censored (IC) data, including: independent interval censorship models, the full likelihood model, various models for C1, C2, and MIC data as well as multivariate IC models. Part II consists of seven chapters (3-9). Chapters 3, 4 and 5 deal with interval-censored methods for current status data. In Chapter 3, Banerjee presents: likelihood based inference, more general forms of interval censoring, competing risks, smoothed estimators, inference on a grid, outcome misclassi- cation, and semiparametric models. In Chapter 4, Zhang presents regression analyses using the proportional hazards model, the proportional odds model, and a linear transformation model, as well as considering bivariate current status data with the proportional odds model. In Chapter 5, Kim, Kim, Nam and Kim develop statistical analysis methods for dependent current status data and utilize the R Package CSD to analyze such data"-- Provided by publisher.
  • 2006 CRCnetBASE
    John N.S. Matthews.
  • 2013
    edited by J. Dennis Blessing, J. Glenn Forister.
    Status: Not Checked OutLane Catalog Record
    Introduction -- Essays on research in the health professions -- Ethics in research -- Regulatory protection of human subjects in research -- Funding the research : grants -- The research problem -- Review of the literature -- Methodology -- Clinical investigations -- Survey research -- The clinical review -- Qualitative research -- Community-based participatory research -- Data analysis -- Results -- Discussion -- References -- What to do with what you have -- Writing and publishing in the health professions -- Interpreting the literature.
  • 2007 Springer
    Pentti Rautaharju and Farida Rautaharju.
  • 2009 Springer
    Ronald R. Gauch.
  • 2012 Springer
    J. Rick Turner.
  • 2010 Springer
    Thanos Athanasiou, Haile Debas, Ara Darzi (eds.).
  • 2006 SAGE
    Michael Bloor and Fiona Wood.
    A practical guide to qualitative techniques for students and researchers across the social and health sciences, this work provides coverage of qualitative methods complemented by extended illustration from the array of academic disciplines in which qualitative research is found and employed.
  • 2008 Springer
    Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz.
  • NAP
    [Panel on IRBs, Surveys and Social Science Research, Cora Marrett, chair].
  • 2014 WorldScientific
    editors, Rakesh Srivastava, Wojciech Maksymowicz, Wlodek Lopaczynski.
    This book is all about the definition and finding ways to prioritize and accelerate translation research in biomedical sciences and rapidly turning new knowledge into first-in-human studies. It represents an effort to bring together scientists active in various areas of translational research to share science and, hopefully, generate new ideas and potential collaborations. The book provides a comprehensive overview of translational work that includes significant discoveries and pioneering contributions, e.g., in immunology, gene therapy, stem cells and population sciences. It may be used as an advanced textbook by graduate students and even ambitious undergraduates in biomedical sciences. It is also suitable for non-experts, i.e. medical doctors, who wish to have an overview of some of the fundamental models in translational research. Managing the translational enterprise remains a work in progress. The world is changing rapidly, and the scientific world needs to seek new ways to ensure that discoveries get translated for patients efficiently and as quickly as possible. In addition, everyone expects the investment in biomedical research should pay dividends through effective therapeutic solutions. This unique project provides a broad collaborative approach of the international scientific team to present its view and opinion how to cross barriers to incentives for translational research in medical sciences. Contributing to the book is an international team of prominent co-authors. The book consists of unique and widely treated topics, and includes new hypotheses, data and analyses.
  • 2013
    S. Lochlann Jain.
    Status: Not Checked OutLane Catalog Record
    "Cancer can kill: this fact makes it concrete. Still, it's a devious knave. Nearly every American will experience it up-close and all too personally, wondering why the billions of research dollars thrown at the word haven't exterminated it from the English language. Like a sapper diffusing a bomb, Jain unscrambles the emotional, bureaucratic, medical, and scientific tropes that create the thing we call cancer. Scientists debate even the most basic facts about the disease, while endlessly generated, disputed, population data produce the appearance of knowledge. Jain takes the vacuum at the center of cancer seriously and demonstrates the need to understand cancer as a set of relationships--economic, sentimental, medical, personal, ethical, institutional, statistical. Malignant analyzes the peculiar authority of the socio-sexual psychopathologies of body parts; the uneven effects of expertise and power; the potentially cancerous consequences of medical procedures such as IVF; the huge industrial investments that manifest themselves as bone-cold testing rooms; the legal mess of medical malpractice law; and the teeth-grittingly jovial efforts to smear makeup and wigs over the whole messy problem of bodies spiraling into pain and decay. Malignant examines the painful cognitive dissonances produced by the ways a culture that has relished dazzling success in every conceivable arena have twisted one of its staunchest failures into an economic triumph. The intractable foil to American achievement, cancer hands us -- on a silver platter and ready for Jain's incisively original dissection -- our sacrifice to the American Dream"-- Provided by publisher.
  • 2015 ScienceDirect
    Peter J. Snyder, Linda C. Mayes, William E. Smith.
    The Management of Scientific Integrity within Academic Medical Centers discusses the impact scientific misconduct has in eight complex case studies. Authors look at multifaceted mixtures of improper behavior, poor communication, cultural issues, adverse medical/health issues, interpersonal problems and misunderstandings to illustrate the challenge of identifying and managing what went wrong and how current policies have led to the establishment of quasi legal processes within academic institutions. The book reviews the current global regulations and concludes with a section authored by a US federal court judge who provides his perspective on the adequacy of current regulations and policies.
  • 2014 Springer
    by Silvia M. Rogers.
    This self-help guide is intended for scientists and medical professionals and students who wish to improve their scientific writing skills. Exercises invite the reader to practice the most important aspects of scientific writing. Although the book addresses certain issues more troublesome to scientific communicators of a non-English language origin, the guide will be of equal benefit to those whose first language is English. If you want not only to write but to write well, this book is for you. This second edition takes into account new developments in the area of scientific communication. In particular, the importance of authenticity is addressed, drawing attention to the sensitive issue of plagiarism in scientific texts.
  • 2007 Springer
    Silvia M. Rogers.
  • 2011 CRCnetBASE
    Mohamed M. Shoukri.
    "Emphasizing applications over theory, this book provides a comprehensive survey of this method and provides readers with standards and directions on how to run sound clinical and other types of studies. The author clearly explains how to reduce measurement error and presents numerous practical examples of the interobserver agreement approach. To help with problem solving, he includes SAS code, both within the book and on the CRC website. An extensive review of the literature offers access to the latest developments in the field. This edition presents new applications, new tables, more detail on SAS, new code, updated references, and two new chapters"--Provided by publisher.
  • Click LINK above for Print location/circulation status.
    2006 CRCnetBASE
    [edited by] Theodore R. Kucklick.
  • 2010 WHO
    Also available: Print – 2010
  • 2011 Springer
    Robert B. Taylor.
    Getting Started in Medical Writing -- Basic Writing Skills -- From Page One to the End -- Technical Issues in Medical Writing -- What's Special About Medical Writing? -- How to Write a Review Article -- Case Reports, Editorials, Letters to the Editor, Book Reviews, and Other Publication Models -- Writing Book Chapters and Books -- How to Write a Research Protocol -- How to Write a Grant Proposal -- How to Write a Report of a Clinical Study -- Getting Your Writing Published.
  • 2011 Springer
    David A. Schwartz, editor.
    Physician-scientists are unusual creatures. While we are drawn to the clinical challenges of our patients, we are also drawn to the opportunities that our patients' medical problems bring to science. This book contains the unique experiences and encounters that drew 21 accomplished physician-scientists to this profession. These personal stories are those of people and circumstances that have had profound effects on our career decisions, our creative opportunities, and our lives. These stories also serve to highlight the lessons learned along the way and the distinct attributes of these women and men of medicine and science. Our combined hope is that our collective biographies will enhance the public understanding of our profession, will move people from medicine to science and from science to medicine, and will inspire those who are contemplating this extraordinary profession.
  • 2008 CRCnetBASE
    Dankmar Böhning, Ronny Kuhnert, Sasivimol Rattanasiri.
  • 2014 Wiley
    edited by N. Balakrishnan.
  • 2014 Wiley
    edited by N. Balakrishnan.
  • v. 1-5, 1962-66.
    Dorfman, Ralph I.
    Status: Not Checked OutLane Catalog Record
    v. 1. Chemical determinations -- v. 2. Bioassay -- v. 3. & 4. Steroidal activity in experimental animals and man, Part A & B.
  • 2011 Springer
    William C.S. Cho, editor.
    1 -- MicroRNAs in Cancer (An Overview) -- 2. The Role of MicroRNAs in Lung Cancer Development, Progression, and Metastasis -- 3. MicroRNAs in Breast Cancer -- 4. MicroRNAs in Colorectal Cancer -- 5. MicroRNAs in Gastric Cancer -- 6. MicroRNAs in Prostate Cancer: A Possible Role as Novel Biomarkers and Therapeutic Targets?- 7. MicroRNAs in Hepatocellular Carcinoma -- 8. MicroRNAs in Cervical Carcinoma -- 9. MicroRNAs in Esophageal Cancer -- 10. MicroRNAs in Bladder Cancer -- 11. MicroRNAs in Lymphoma -- 12. MicroRNAs in Leukemia -- 13. MicroRNAs in Pancreatic Cancer: Potential Interests as Biomarkers and Therapeutic Tools -- 14. MicroRNAs in Epithelial Ovarian Cancer -- 15. MicroRNAs in Brain Tumors -- 16. MicroRNAs and Cancer Stem Cells -- 17. MicroRNAs in Cancer Invasion and Metastasis -- 18. MicroRNAs in Predicting Radiotherapy and Chemotherapy Response -- 19. Role of MicroRNAs in Anti-cancer Drug Resistance -- 20. MicroRNAs and Cancer Metabolism -- 21. MicroRNAs as Blood-based Biomarkers of Cancer -- 22. RNAi-based Approaches to the Treatment of Brain Tumors.
  • 2011
  • 2003 Wellcome Trust
    edited by L.A. Reynolds and E.M. Tansey.
    "This transcript considers the origins and impact of the MRC Applied Psychology Unit's work from 1944 to 1998."
  • 2006 ScienceDirect
    edited by Ray Paton and Laura A. McNamara.
  • 2013 Wiley
    James R. Carpenter, Michael G. Kenward.
    Introduction -- The multiple imputation procedure and its justification -- Multiple imputation of quantitative data -- Multiple imputation of binary and ordinal data -- Multiple imputation of unordered categorical data -- Nonlinear relationships -- Interactions -- Survival data, skips and large datasets -- Multilevel multiple imputation -- Sensitivity analysis: MI unleashed -- Including survey weights -- Robust multiple imputation.
  • 2010 CRCnetBASE
    edited by Alex Dmitrienko, Ajit C. Tamhane, Frank Bretz.
    1. Multiplicity problems in clinical trials : a regulatory perspective / Mohammad Huque and Joachim Rèohmel -- 2. Multiple testing methodology / Alex Dmitrienko ... [et al.] -- 3. Multiple testing in dose-response problems / Frank Bretz, Ajit C. Tamhane, and Josâe Pinheiro -- 4. Analysis of multiple endpoints in clinical trials / Ajit C. Tamhane and Alex Dmitrienko -- 5. Gatekeeping procedures in clinical trials / Alex Dmitrienko and Ajit C. Tamhane -- 6. Adaptive designs and confirmatory hypothesis testing / Willi Maurer, Michael Branson, and Martin Posch -- 7. Design and analysis of microarray experiments for pharmacogenomics / Jason C. Hsu ... [et al.].
  • 2011 CRCnetBASE
    Damon M. Berridge, Robert Crouchley.
    Machine generated contents note: 2.1. Introduction -- 2.2. Continuous/interval scale data -- 2.3. Simple and multiple linear regression models -- 2.4. Checking assumptions in linear regression models -- 2.5. Likelihood: multiple linear regression -- 2.6. Comparing model likelihoods -- 2.7. Application of a multiple linear regression model -- 2.8. Exercises on linear models -- 3.1. Binary data -- 3.1.1. Introduction -- 3.1.2. Logistic regression -- 3.1.3. Logit and probit transformations -- 3.1.4. General logistic regression -- 3.1.5. Likelihood -- 3.1.6. Example with binary data -- 3.2. Ordinal data -- 3.2.1. Introduction -- 3.2.2. The ordered logit model -- 3.2.3. Dichotomization of ordered categories -- 3.2.4. Likelihood -- 3.2.5. Example with ordered data -- 3.3. Count data -- 3.3.1. Introduction -- 3.3.2. Poisson regression models -- 3.3.3. Likelihood -- 3.3.4. Example with count data -- 3.4. Exercises -- 4.1. Introduction -- 4.2. The linear model 4.3. The binary response model -- 4.4. The Poisson model -- 4.5. Likelihood -- 5.1. Introduction -- 5.2. Linear mixed model -- 5.3. The intraclass correlation coefficient -- 5.4. Parameter estimation by maximum likelihood -- 5.5. Regression with level-two effects -- 5.6. Two-level random intercept models -- 5.7. General two-level models including random intercepts -- 5.8. Likelihood -- 5.9. Residuals -- 5.10. Checking assumptions in mixed models -- 5.11. Comparing model likelihoods -- 5.12. Application of a two-level linear model -- 5.13. Two-level growth models -- 5.13.1. A two-level repeated measures model -- 5.13.2. A linear growth model -- 5.13.3. A quadratic growth model -- 5.14. Likelihood -- 5.15. Example using linear growth models -- 5.16. Exercises using mixed models for continuous/interval scale data -- 6.1. Introduction -- 6.2. The two-level logistic model -- 6.3. General two-level logistic models -- 6.4. Intraclass correlation coefficient -- 6.5. Likelihood -- 6.6. Example using binary data -- 6.7. Exercises using mixed models for binary data 7.1. Introduction -- 7.2. The two-level ordered logit model -- 7.3. Likelihood -- 7.4. Example using mixed models for ordered data -- 7.5. Exercises using mixed models for ordinal data -- 8.1. Introduction -- 8.2. The two-level Poisson model -- 8.3. Likelihood -- 8.4. Example using mixed models for count data -- 8.5. Exercises using mixed models for count data -- 9.1. Introduction -- 9.2. The mixed linear model -- 9.3. The mixed binary response model -- 9.4. The mixed Poisson model -- 9.5. Likelihood -- 10.1. Introduction -- 10.2. Three-level random intercept models -- 10.3. Three-level generalized linear models -- 10.4. Linear models -- 10.5. Binary response models -- 10.6. Likelihood -- 10.7. Example using three-level generalized linear models -- 10.8. Exercises using three-level generalized linear mixed models -- 11.1. Introduction -- 11.2. Multivariate two-level generalized linear model -- 11.3. Bivariate Poisson model: example -- 11.4. Bivariate ordered response model: example -- 11.5. Bivariate linear-probit model: example -- 11.6. Multivariate two-level generalized linear model likelihood 11.7. Exercises using multivariate generalized linear mixed models -- 12.1. Introduction -- 12.1.1. Left censoring -- 12.1.2. Right censoring -- 12.1.3. Time-varying explanatory variables -- 12.1.4. Competing risks -- 12.2. Duration data in discrete time -- 12.2.1. Single-level models for duration data -- 12.2.2. Two-level models for duration data -- 12.2.3. Three-level models for duration data -- 12.3. Renewal data -- 12.3.1. Introduction -- 12.3.2. Example: renewal models -- 12.4. Competing risk data -- 12.4.1. Introduction -- 12.4.2. Likelihood -- 12.4.3. Example: competing risk data -- 12.5. Exercises using renewal and competing risks models -- 13.1. Introduction -- 13.2. Mover-stayer model -- 13.3. Likelihood incorporating the mover-stayer model -- 13.4. Example 1: stayers within count data -- 13.5. Example 2: stayers within binary data -- 13.6. Exercises: stayers -- 14.1. Introduction to key issues: heterogeneity, state dependence and non-stationarity -- 14.2. Example -- 14.3. Random effects models -- 14.4. Initial conditions problem -- 14.5. Initial treatment 14.6. Example: depression data -- 14.7. Classical conditional analysis -- 14.8. Classical conditional model: example -- 14.9. Conditioning on initial response but allowing random effect uol to be dependent on z3 -- 14.10. Wooldridge conditional model: example -- 14.11. Modelling the initial conditions -- 14.12. Same random effect in the initial response and subsequent response models with a common scale parameter -- 14.13. Joint analysis with a common random effect: example -- 14.14. Same random effect in models of the initial response and subsequent responses but with different scale parameters -- 14.15. Joint analysis with a common random effect (different scale parameters): example -- 14.16. Different random effects in models of the initial response and subsequent responses -- 14.17. Different random effects: example -- 14.18. Embedding the Wooldridge approach in joint models for the initial response and subsequent responses -- 14.19. Joint model incorporating the Wooldridge approach: example -- 14.20. Other link functions -- 14.21. Exercises using models incorporating initial conditions/state dependence in binary data 15.1. Introduction -- 15.2. Fixed effects treatment of the two-level linear model -- 15.3. Dummy variable specification of the fixed effects model -- 15.4. Empirical comparison of two-level fixed effects and random effects estimators -- 15.5. Implicit fixed effects estimator -- 15.6. Random effects models -- 15.7. Comparing two-level fixed effects and random effects models -- 15.8. Fixed effects treatment of the three-level linear model -- 15.9. Exercises comparing fixed effects and random effects -- A.1. SabreR installation -- A.2. SabreR commands -- A.2.1. The arguments of the SabreR object -- A.2.2. The anatomy of a SabreR command file -- A.3. Quadrature -- A.3.1. Standard Gaussian quadrature -- A.3.2. Performance of Gaussian quadrature -- A.3.3. Adaptive quadrature -- A.4. Estimation -- A.4.1. Maximizing the log likelihood of random effects models -- A.5. Fixed effects linear models -- A.6. Endogenous and exogenous variables -- B.1. Getting started with R -- B.1.1. Preliminaries -- B.1.1.1. Working with R in interactive mode -- B.1.1.2. Basic functions -- B.1.1.3. Getting help B.1.1.4. Stopping R -- B.1.2. Creating and manipulating data -- B.1.2.1. Vectors and lists -- B.1.2.2. Vectors -- B.1.2.3. Vector operations -- B.1.2.4. Lists -- B.1.2.5. Data frames -- B.1.3. Session management -- B.1.3.1. Managing objects -- B.1.3.2. Attaching and detaching objects -- B.1.3.3. Serialization -- B.1.3.4. R scripts -- B.1.3.5. Batch processing -- B.1.4. R packages -- B.1.4.1. Loading a package into R -- B.1.4.2. Installing a package for use in R -- B.1.4.3. R and Statistics -- B.2. Data preparation for SabreR -- B.2.1. Creation of dummy variables -- B.2.2. Missing values -- B.2.3. Creating lagged response covariate data.
  • 2010 NAP
    Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services.
    Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials.
  • 2015
    Mary Moran, Nick Chapman, Lisette Abela-Oversteegen, Vipul Chowdhary, Anna Doubell, Christine Whittall, Rachel Howard, Penny Farrell, Dale Halliday, Catherine Hirst.
    In 2014, a reported $3,377m was invested in neglected disease R&D, consisting of $3,197m from repeat survey participants (called year-on-year -- YOY -- funders) and $179m from irregular survey participants. Total YOY funding for neglected disease R&D increased by $150m (up 4.9%), but this was entirely the result of significant new investment in Ebola R&D in response to the 2014 West African Ebola epidemic. Without Ebola, YOY funding for neglected disease R&D would have been essentially unchanged from 2013 (down $14m, -0.4%).
  • 2012 Springer
    Jill Scott, Esther Stoeckli, editors.
    Neural Development -- Visual Perception -- Tactile Perception -- Skin And Environment -- Conclusion: Neuromedia: Talking into the Future.
  • NIH
    [Harold Varmus], Office of Director, National Institutes of Health.
  • NIH
    National Institutes of Health.
  • 2012
    Pei He.
    In clinical trials, enrolled patients are randomized into treatment and control groups to test if the new treatment has advantages over the control. Data have been collected from both groups to form test statistics. For life-threatening diseases, such as cancer and heart attacks, the primary endpoint of a confirmatory trial for a new treatment is time to failure. This endpoint often involves censored data because some subjects may not fail by the end of the study or may have been lost to follow-up. To handle survival data in the problem of explanatory variables, Cox (1972) introduced a semi-parametric model based on the assumption of proportional hazards. In this model, the log ratio of the hazard function of the treatment group to that of the control group is a constant that does not vary over time. Earlier Mantel (1966) introduced the logrank test that is asymptotically efficient for proportional hazards alternative. Both logrank test and proportional hazards regression model have become standard procedures in clinical trials with survival endpoints. Since clinical trials can run for years, interim analyses by a Data and Safety Monitoring Board (DSMB) are typically included in the trial protocol. This led to the development of "time-sequential'' methods for early stopping during interim analyses. Lan and DeMets (1988) have noted that there are two time scales in time-sequential trials. One is the calendar time t at which interim analysis is carried out, and the other is the information time V(t), which can be measured by the variance of the test statistic (under the null hypothesis) based on all the data collected up to time t and is unknown before time t. Therefore, to determine the sample size and study duration, assumptions have to be made on the accrual rate, the survival distribution of both treatment and control groups, and the censoring distribution. These assumptions are commonly based on the literature concerning related studies and on educated guesses. In particular, since logrank tests and time-invariant hazard ratios are typically used to summarize the results of the studies, it is convenient to assume proportional hazards as the working model at the design stage. During interim analyses, marked discrepancies for the assumptions at the design stage may be observed. Herein we propose a group sequential design that addresses theses discrepancies and thereby makes the trial more efficient in terms of power, study duration and expected sample size. The design allows one to combine the logrank statistic with the more powerful test statistics in case of non-proportional hazards at the terminal stage. A new approach to futility stopping is developed as well as a piecewise constant hazard ratio model replacing the proportional hazards model.
  • 2008 Springer
    Minoru Onozuka, Chen-Tung Yen, editors.
  • v. 1-2, 1978-82.
    edited by Jørgen Fogh, Beppino C. Giovanella.
    Status: Not Checked OutLane Catalog Record
  • 2010 Springer
    William C.S. Cho, editor.
  • 2011 Springer
    Gustavo Duque, Ken Watanabe (editors).
    How to Select Your Animal Model for Osteoporosis Research / A. Simon Turner -- Skeletal Phenotyping in Rodents: Tissue Isolation and Manipulation / Janet E. Henderson, Chan Gao and Edward J. Harvey -- Methods in Bone Biology in Animals: Biomechanics / José B. Volpon and Antonio C. Shimano -- Methods in Bone Histomorphometry for Animal Models / Natalie Dion, Audray Fortin and Louis-Georges Ste-Marie -- Methods in Bone Biology in Animals: Imaging / Blaine A. Christiansen and Mary L. Bouxsein -- Methods in Bone Biology in Animals: Biochemical Markers / Markus Herrmann -- Methods in Bone Biology: Cancer and Bone / Yu Zheng, Markus J. Seibel and Hong Zhou -- How to Test Osteoporosis Treatments in Experimental Animals / Robert J. van ʻt Hof -- The Ovariectomized Mice and Rats / Jameela Banu -- Classical Models of Senile Osteoporosis / Ken Watanabe -- Animal Models of Premature Aging / Wei Li and Gustavo Duque -- Nonhuman Primate Models of Osteoporosis / Susan Y. Smith, Aurore Varela and Jacquelin Jolette -- Other Large Animal Models / Susan Reinwald and David B. Burr -- Mouse models for the Study of Fracture Healing and Bone Regeneration / Joerg H. Holstein, Patric Garcia, Tina Histing, Moritz Klein and Steven C. Becker, et al.
  • edited by H.C.G. Matthew and Brian Harrison.
  • Includes all of words, phrases, and translations, in French, German, Spanish and Italian from the print dictionaries. Users can search the full A-Z from both sides of the dictionary in Oxford's unabridged bilingual dictionaries: French, German, Spanish, and Italian.
  • 2008 ebrary
    2008 CRCnetBASE
    edited by Tony Kennedy.
    Strategic project management at the project level / Tony Kennedy -- Strategic project management at the portfolio level / Kevin Bilyard and Des Markland -- Project planning : from basic concepts to systems application / Carl A. Kutzbach, Carole Strong, and Sylvia Walker -- Project management of chemical, analytical, and formulation development / Dieter Krimmer -- Project management in exclusive synthesis / Lukas M.J. von Hippel -- Clinical trials--can they be project managed? / Les Rose -- Regulatory project management / Nicholas Wells -- Teams / Ralph White -- Project management and outsourcing drug development / Jon Court and Mark Fowler -- The project management function / Tony Kennedy.
    Also available: Print – 2008
  • 2011 Springer
    Mark J. Eisenberg.
    pt. 1. Getting started as physician-scientist. -- Beginnings -- Is a physician-scientist career right for you? -- Training as a physician-scientist -- pt. 2. Launching your career as a physician-scientist. -- Getting a job -- Appointments, tenure, promotions, and sabbaticals -- Teaching -- Administration -- Research -- pt. 3. Building your career as a physician-scientist. -- Writing -- Publishing -- Grants -- Grantsmanship -- Peer review of grant applications -- Managing your team, time, and money -- Mentorship -- Lectures and presentations -- Relations with industry -- pt. 4. Parting words of advice : putting it all together. -- Balancing research, clinical activities, and family life -- Improving the physician-scientist pathway -- Concluding remarks.
  • 2012 Springer
    edited by Zdenko Machala, Karol Hensel, and Yuri Akishev.
  • 1924-
    collected by the Engineering foundation, New York, Jan. l5, 1921.
    Status: Not Checked OutLane Catalog Record
  • 2008 Springer
    Berryman, A. A.; Berryman, A. A.; Kindlmann, Pavel.
  • 2002 Wellcome
    edited by A.R. Ness, L.A. Reynolds, E.M. Tansey.
  • 2006 CRCnetBASE
    Graham D. Ogg.
  • 2005 Springer
    Dan Bader ... [et al.] (eds.).
  • 2007
    [edited by] John I. Gallin, Frederick P. Ognibene.
    Status: Not Checked OutLane Catalog Record
  • 2012 ScienceDirect
    edited by John Gallin, Frederick P. Ognibene.
    This expanded third edition provides an introduction to the conduct of clinical research as well as more comprehensive and expansive content about the infrastructure necessary for a successful clinical research organization or enterprise. With authors who are experts in clinical research in both the public and private sectors, this publication provides essential information to clinical investigators who wish to develop and conduct well designed patient-based research protocols that comply with rigorous study design, ethical, and regulatory requirements.
  • 2011 Springer
    edited by Manuel Hidalgo, S. Gail Eckhardt, Elizabeth Garrett-Mayer, Neil J. Clendeninn.
    Basic biostatistics for the clinical trialist / Elizabeth G. Hill and Elizabeth Garrett-Mayer -- Fundamental concepts in clinical pharmacology / Daniel L. Gustafson and Erica L. Bradshaw-Pierce -- Bioanalycial methods in clinical drug development / Walter J. Loos, Peter de Bruijn and Alex Sparreboom -- Preclinical models for anticancer drug development / Edward A. Sausville -- Phase I clinical trials with anticancer agents / Stephen Leong ... [et al.] -- Phase II trials with anticancer agents / Hui K. Gan, J. Jack Lee and Lillian L. Siu -- Phase III clinical trials with anticancer agents / Wendy R. Parulekar and Daniel J. Sargent -- Pharmacokinetic studies in early anticancer drug development / Alex Sparreboom and Sharyn D. Baker -- Pharmacodynamic studies in early phase drug development / D. Ross Camidge, Robert C. Doebele and Antonio Jimeno -- Prediction of antitumor response / Fred R. Hirsch and Yu Shyr -- Imaging studies in anticancer drug development / David A. Mankoff -- Role of the U.S. Food and Drug Administration in cancer drug development / Ann T. Farrell, Ramzi N. Dagher and Richard Pazdur -- Early clinical trials with cytotoxic agents / M.J.A. de Jonge and Jaap Verweij -- Challenges and successes in developing effective anti-angiogenic agents / Laura Q.M. Chow and S. Gail Eckhardt -- Targeted therapeutics in cancer treatment / Colin D. Weekes and Manuel Hidalgo -- Cancer chemoprevention / Christopher H. Lieu, William N. William Jr. and Scott Lippman -- Combined modality therapy in cancer management / David Raben and Kyle Rusthoven -- Cancer vaccines / Daniel Laheru -- Optimising the development of antibodies as treatment for cancer / Craig P. Carden, Hendrik-Tobias Arkenau and Johann S. de Bono -- Oligonucleotide therapeutics / Cy A. Stein, Britta Hoehn and John Rossi -- Anticancer drug development in pediatric patients / Lia Gore and Margaret Macy -- Clinical trials in special populations / S. Percy Ivy ... [et al.] -- NCI-sponsored clinical trials / Andriana Papaconstantinou and Janet E. Dancey.
  • 2012 Springer
    Phyllis G. Supino, Jeffrey S. Borer, editors ; foreword by Stephen E. Epstein.
  • 2015 ScienceDirect
    edited by Martin Wehling, Department of Clinical Pharmacology Mannheim, University of Heidelberg, Mannheim, Germany.
    Principles of Translational Science in Medicine: From Bench to Bedside, Second Edition, provides an update on major achievements in the translation of research into medically relevant results and therapeutics. The book presents a thorough discussion of biomarkers, early human trials, and networking models, and includes institutional and industrial support systems. It also covers algorithms that have influenced all major areas of biomedical research in recent years, resulting in an increasing numbers of new chemical/biological entities (NCEs or NBEs) as shown in FDA statistics. The book is ideal for use as a guide for biomedical scientists to establish a systematic approach to translational medicine.
  • 2010
    edited by Martin Wehling ; foreword by Francesco M. Marincola.
    Status: Not Checked OutLane Catalog Record
    Introduction and definitions -- Target identification and validation -- Biomarkers -- Early clinical trial design -- Pharmaceutical toxicology -- Translational science biostatistics -- Learning by experience : examples of translational processes in the cardiovascular field.
  • 2011 WHO
    Background -- Scope, goal, objectives and target audience -- Global burden of NCDs -- Role of research in the implementation of the Global Strategy Action Plan -- Need for a prioritized research agenda for prevention and control of major NCDs to improve public health -- Achievable outcomes through a prioritized research agenda for prevention and control of major NCDs -- Process for the development of the WHO NCD research agenda. Initial phase of development of the WHO NCD research agenda -- Ranking process -- Finalization of WHO NCD research agenda -- Key domains for research. Major NCDs. Cardiovascular disease (CVD) -- Cancer -- Chronic respiratory diseases -- diabetes -- NCD risk factors. Tobacco control -- Nutrition, physical activity and obesity -- Cross-cutting domains. Primary health care approach for prevention and control of NCDs -- Social determinants and NCDs -- Genetics -- Promoting use of research findings to policies and practice for prevention and control of noncommunicable diseases -- Top 20 priority areas for NCD research -- Key elements required for strengthening the research capacity of low- and middle-income countries for implementation of the WHO NCD research agenda. Contents of the compact disc: -- 1. Working papers -- 2. Reports of Meetings to develop the Prioritized NCD research agenda (2008-2010) -- 3. Lists of participants -- 4. List of other contributors and institutions that participated in the process of development and review of the prioritized NCD research agenda.
    Also available: Print – 2011
  • v. 1-2, 1966-71.
    edited by G. L. Cantoni & David R. Davies.
    Status: Not Checked OutLane Catalog Record
  • v. 3-27, 1969-94. Karger
    Also available: Print – v. 8, 1975.
  • 2002 AAMC
    Task Force on Financial Conflicts of Interest in Clinical Research.
  • 2007 Karger
    volume editors, P. Porcelli, N. Sonino.
    Development of a new assessment strategy in psychosomatic medicine: the diagnostic criteria for psychosomatic research / S. Fabbri ... [et al.] -- Psychosocial approach to endocrine disease / N. Sonino, E. Tomba, G.A. Fava -- Psychological factors affecting functional gastrointestinal disorders / P. Porcelli, O. Todarello -- Psychological factors affecting oncology conditions / L. Grassi ... [et al.] -- Psychological factors affecting cardiologic conditions / C. Rafanelli ... [et al.] -- Toward a biopsychosocial approach to skin diseases / A. Picardi, P. Pasquini -- Psychological factors affecting medical conditions in consultation-liaison psychiatry / A. Bellomo ... [et al.] -- Psychological factors affecting medical conditions in consultation-liaison psychiatry / A. Bellomo ... [et al.] -- Psychological factors affecting eating disorders / S. Fassino ... [et al.].
  • 2015 Springer
    Omar C.G. Gelo, Alfred Pritz, Bernd Rieken, editors.
    This book provides readers with essential information on the foundations of psychotherapy research, and on its applications to the study of both psychotherapy process and outcome. The aim is to stimulate a reflection on these issues in a way that will benefit researchers and clinicians, as well as undergraduate and graduate students, at different levels and from different perspectives. Accordingly, the book presents a balanced mix of chapters summarizing the state of the art in the field from different viewpoints and covering innovative topics and perspectives, reflecting some of the most established traditions and, at the same time, emerging approaches in the field in several countries. The contributors, who were invited from among the experts in our national and international professional networks, also represent a healthy mix of leading figures and young researchers. The first part of the book addresses a number of fundamental issues in psychotherapy research at a historical, philosophical, and theoretical level. The second part of the book is concerned with research on psychotherapy processes; in this regard, both quantitative and qualitative approaches are given equal consideration in order to reflect the growing relevance of the latter. The book's third and last part examines research on psychotherapy outcomes, primarily focusing on quantitative approaches. Offering a balanced mix of perspectives, approaches and topics, the book represents a valuable tool for anyone interested in psychotherapy research.
  • 2006
    Warren S. Browner.
    Status: Not Checked OutLane Catalog Record
    Overview -- Title and abstract -- Introduction -- Methods -- Results -- Tables -- Figures -- Discussion -- References and electronic publishing -- Authorship -- Posters -- Oral presentations -- Choosing a journal and responding to reviews -- Suggestions for writing well.
  • 2006 Wiley
    edited by Catherine Pope, Nicholas Mays.
    Qualitative methods in health research / Catherine Pope, Nicholas Mays -- Qualitative interviews / Nicky Britten -- Focus groups / Jenny Kitzinger -- Observational methods / Catherine Pope, Nicholas Mays -- Conversation analysis / Sarah Collins, Nicky Britten -- Ethical issues / Dawn Goodwin -- Analysing qualitative data / Catherine Pope, Sue Ziebland, Nicholas Mays -- Quality in qualitative health research / Nicholas Mays, Catherine Pope -- Combining qualitative and quantitative methods / Alicia O'Cathain, Kate Thomas -- Case studies / Justin Keen -- Action research / Julienne Meyer -- Consensus development methods / Nick Black -- Synthesising qualitative research / Catherine Pope and Nicholas Mays.
  • 2005 Springer
    edited by Daniel T.L. Shek, Ying Keung Chan, and Paul S.N. Lee.
  • 2012 CRCnetBASE
    edited by Isabelle Boutron, Philippe Ravaud, David Moher.
    "Nonpharmacological treatments include a wide variety of treatments such as surgery, technical procedures, implantable devices, nonimplantable devices, rehabilitation, psychoteherapy, and behavioral interventions. This book focuses on the methods of assessing nonpharmacological treatments, highlighting specific issues and discussing all possible design of trials. It provides practical examples to underline the issues and solutions in assessing nonpharmacological treatment in trials. Arguably the first book to exclusively explore this topic, it discusses various categories of treatments from surgical procedures to psychotherapy"--Provided by publisher.
  • 2012 ScienceDirect
    [edited by] Xin-Yuan Liu, Sidney Pestka, Yu-Fang Shi.
    Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super.
  • 2006
    Kay Ann Cassell and Uma Hiremath.
    Status: Not Checked OutLane Catalog Record
  • 2011 NAP
    Committee on Advancing Pain Research, Care, and Education, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
    1. Introduction -- 2. Pain as a Public Health Challenge -- 3. Care of People with Pain -- 4. Education Challenges -- 5. Research Challenges -- 6. A Blueprint for Transforming Pain Prevention, Care, Education, and Research -- Glossary -- A. Data Sources and Methods -- B. Summary of Written Public Testimony -- C. The Economic Costs of Pain in the United States -- D. Committee and Staff Biographies.
  • 2010 WHO
    "This overview outlines the statutory background for WHO's research, identifies the milestones in health research over five decades, and discusses issues of both process and programs. This report also includes accounts of regional efforts in health research"--Publisher's description. African region; Eastern Mediterranean region; European region; South East Asia region; Western Pacific region; Pan American Health Organization
    Also available: Print – 2010
  • 2014 ebrary
    edited by Joyce M. Ray.
    It has become increasingly accepted that important digital data must be retained and shared in order to preserve and promote knowledge, advance research in and across all disciplines of scholarly endeavor, and maximize the return on investment of public funds. To meet this challenge, colleges and universities are adding data services to existing infrastructures by drawing on the expertise of information professionals who are already involved in the acquisition, management and preservation of data in their daily jobs. Data services include planning and implementing good data management practices, thereby increasing researchers' ability to compete for grant funding and ensuring that data collections with continuing value are preserved for reuse. This volume provides a framework to guide information professionals in academic libraries, presses, and data centers through the process of managing research data from the planning stages through the life of a grant project and beyond. It illustrates principles of good practice with use-case examples and illuminates promising data service models through case studies of innovative, successful projects and collaborations.
  • 2013 Cambridge
    [edited by] Gary L. Comstock.
    "Ordinarily, responsible conduct of research (RCR) 'training' consists of lectures accompanied by generic exercises on 'core' topics. Research Ethics takes a novel, philosophical approach to the RCR and the teaching of moral decision-making. Part I introduces egoism and explains that it is in the individuals own interest to avoid misconduct, fabrication of data, plagiarism and bias. Part II takes up contractualism and covers issues of authorship, peer review and responsible use of statistics. Part III introduces moral rights as the basis of informed consent, the use of humans in research, mentoring, intellectual property and conflicts of interests. Part IV uses two-level utilitarianism to explore the possibilities and limits of the experimental use of animals, duties to the environment and future generations, and the social responsibilities of researchers. This book replaces mind-numbing rote exercises with an adventure in moral imagination and is an essential guide for graduate students in all disciplines"-- Provided by publisher.
  • 2013 Springer
    Daron Smith, Dan Wood.
    Research in Clinical Practice is a neat, pocket-sized reference guide examining how to get the most from actively participating in research. Including how to begin, avoiding pitfalls, whom to approach and what questions to ask - all significant practicalities for conducting research in the reader's area of interest. Each reader will learn how to make the best use of such a valuable time. Written by two experienced surgeons, both of whom achieved post graduate research degrees, Research in Clinical Practice, is an essential tool for clinicians embarking on a research project as well as those who are new to supervising researchers.
  • 2008 Stanf Univ
    Topics include self-Management, self-Efficacy, health Status, and some diabetes-specific scales.
  • 2007
    [edited by] Julia M. Addington-Hall, Eduardo Bruera, Irene J. Higginson, Sheila Payne.
    Status: Not Checked OutLane Catalog Record
    Ethical and practice issues in qualitative research / Frances Sheldon and Anita Sargeant -- Evaluating qualitative research / Michelle Crossley -- Mixed methods for evaluation research / Christine Ingleton and Sue Davies -- Ethnography / Jane Seymour -- Documentary analysis and policy / Margaret O'Connor -- How to develop a research question / Laura Kelly and Patrick Stone -- Writing a research proposal / Chris Todd -- How to gain research ethics approval / Peter Speck -- How to use a statistician / Malcolm Campbell -- How to write a paper / Julia M. Addington-Hall. Principles of designing clinical trials in palliative care / Michael I. Bennett -- Ethical and practical issues in designing and conducting clinical trials in palliative care / Yolanda Zuriarrain Reyna, Michael I. Bennett, and Eduardo Bruera -- Survey design / Julia M. Addington-Hall -- Survey research : methods of data collection, questionnaire design, and piloting / Julia M. Addington-Hall -- Experimental and quasi-experimental designs / Massimo Costantini and Irene J. Higginson -- Outcome measurement / Irene J. Higginson and Richard Harding -- Systematic reviews / Marjolein Gysels and Irene J. Higginson -- Qualitative methods of data collection and analysis / Sheila Payne --
  • 2013 ebrary
    Barbara K. Redman.
  • 2015 ScienceDirect
    edited by Mark A. Suckow, University of Notre Dame, Office of Research Notre Dame, IN, USA ; Bill J. Yates, University of Pittsburgh, Department of Otolaryngology Pittsburgh, PA, USA.
    Ch. 1. Human subjects research protections -- Ch. 2. Investigational new drug and device exemption process -- Ch. 3. The institutional animal care and use committee -- Ch. 4. Biological hazards and select agents -- Ch. 5. Radiological hazards and lasers -- Ch. 6. Controlled substances: maintaining institutional compliance -- Ch. 7. Export controls and US research universities -- Ch. 8. Data management and research integrity -- Ch. 9. Intellectual property -- Ch. 10. Financial conflicts of interest in research -- Ch. 11. Good laboratory practices (GLPs) -- Ch. 12. Human embryonic stem cell research oversight: a confluence of voluntary self-regulation and shifting policy initiatives -- Index.
  • 2011 ebrary
    Committee to Study the National Needs for Biomedical, Behavioral, and Research Personnel, Board on Higher Education and Workforce, Policy and Global Affairs, National Research Council of the National Academies.
    "Comprehensive research and a highly trained workforce are essential for the improvement of health and health care both nationally and internationally. Over the past 40 years the National Research Services Award (NRSA) Program has played a large role in training the workforce responsible for dramatic advances in the understanding of various diseases and new insights that have led to more effective and targeted therapies. In spite of this program, the difficulty obtaining jobs after the postdoc period has discouraged many domestic students from pursuing graduate postdoc training. In the United States, more than 50 percent of the postdoc workforce is made up of individuals who obtained their Ph. D.s from other countries. Indeed, one can make a strong argument that the influx of highly trained and creative foreigners has contributed greatly to U.S. science over the past 70 years. Research Training in the Biomedical, Behavioral, and Clinical Research Sciences discusses a number of important issues, including: the job prospects for postdocs completing their training; questions about the continued supply of international postdocs in an increasingly competitive world; the need for equal, excellent training for all graduate students who receive NIH funding; and the need to increase the diversity of trainees. The book recommends improvements in minority recruiting, more rigorous and extensive training in the responsible conduct of research and ethics, increased emphasis on career development, more attention to outcomes, and the requirement for incorporating more quantitative thinking in the biomedical curriculum."--Publisher's description.
  • 2007
  • 2000

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page
TO INSTALL, RIGHT CLICK this button.

What is it?

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used by physicians to answer clinical questions quickly and easily at the point of care. Topics are updated daily as new evidence becomes available.Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialtiesProvides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.
CONTACT US